Get the Stockscreener App
1.57
6.08%
0.09
After Hours:
1.59
0.02
+1.27%
60 Degrees Pharmaceuticals Inc stock is traded at $1.57, with a volume of 84,014.
It is up +6.08% in the last 24 hours and down -2.48% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
See More
Previous Close:
$1.48
Open:
$1.52
24h Volume:
84,014
Relative Volume:
0.98
Market Cap:
$4.18M
Revenue:
$1.31M
Net Income/Loss:
$-7.56M
P/E Ratio:
-0.1525
EPS:
-10.2926
Net Cash Flow:
$-8.25M
1W Performance:
+3.97%
1M Performance:
-2.48%
6M Performance:
-67.43%
1Y Performance:
-70.04%
1-Day Range:
$1.49
$1.63
1-Week Range:
$1.4201
$1.63
52-Week Range:
$1.22
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.57 | 3.94M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.480|Chg%:-0.010 - TradingKey
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
60 Degrees updates strategy for ARAKODA and profitability - TipRanks
Frontier tech research, news & data - MLQ.ai
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
Interim Trial Plan Finalized for Tafenoquine Babesiosis Study - TipRanks
60 Degrees Pharmaceuticals readies interim analysis plan for tafenoquine babesiosis trial - TradingView
60 Degrees Pharmaceuticals (SXTP) sets tafenoquine babesiosis interim analysis and sNDA path - Stock Titan
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal - Moomoo
60 Degrees Pharma gets option to pursue tick-borne disease drug - Stock Titan
Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
SXTP | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative
SXTPW | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative
Equity plan hike and reverse split up for 60 Degrees (SXTP) shareholder vote - Stock Titan
60 Degrees Pharma babesiosis study clears safety review - Investing.com UK
60 Degrees Pharma babesiosis study clears safety review By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue - Yahoo Finance Singapore
SXTP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SXTP Forecast — Price Target — Prediction for 2027 - TradingView
60 Degrees Pharmaceuticals, Inc. Actuals & Estimates (BOATS:SXTP) - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Analysts Offer Insights on Healthcare Companies: Galectin Therapeutics (GALT) and Gilead Sciences (GILD) - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Number of shareholders of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
SXTP News | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
60 Degrees Pharmaceuticals Inc (SXTP) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Valuation: PE, PB & Fair Value Analysis - TradingKey
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):